NMDA Receptor GluN2 Subtypes Control Epileptiform Events in the Hippocampus
- 243 Downloads
NMDA receptors (NMDARs) play a key role in synaptic plasticity and excitotoxicity. Subtype-specific role of NMDAR in neural disorders is an emerging area. Recent studies have revealed that mutations in NMDARs are a cause for epilepsy. Hippocampus is a known focal point for epilepsy. In hippocampus, expression of the NMDAR subtypes GluN1/GluN2A and GluN1/GluN2B is temporally regulated. However, the pharmacological significance of these subtypes is not well understood in epileptic context/models. To investigate this, epilepsy was induced in hippocampal slices by the application of artificial cerebrospinal fluid that contained high potassium but no magnesium. Epileptiform events (EFEs) were recorded from the CA1 and DG areas of hippocampus with or without subtype-specific antagonists. Irrespective of the age group, CA1 and DG showed epileptiform activity. The NMDAR antagonist AP5 was found to reduce the number of EFEs significantly. However, the application of subtype-specific antagonists (TCN 201 for GluN1/GluN2A and Ro 25-69811 for GluN1/GluN2B) revealed that EFEs had area-specific and temporal components. In slices from neonates, EFEs in CA1 were effectively reduced by Ro 25-69811, but were largely insensitive to TCN 201. In contrast, EFEs in DG were equally sensitive to both of the subtype-specific antagonists. However, the differential sensitivity for the antagonists observed in neonates was absent in later developmental stages. The study provides a functional insight into the NMDAR subtype-dependent contribution of EFEs in hippocampus of young rats, which may have implications in treating childhood epilepsy and avoiding unnecessary side effects of broad spectrum antagonists.
KeywordsEpileptiform events TCN 201 Ro 25-69811 GluN2A GluN2B and NMDA receptors
We thank Dr. Anoopkumar T for the support, Dr. Shobi Veleri and Dr. Kalyanikutty K P for critically reading this manuscript and discussions, and Dr. John Dempster and Dr. William James Heitler for the software. This work was supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India (Ramalingaswami Re-entry Fellowship to PP, No. BT/RLF/Re-entry/04/2012).
Compliance with Ethical Standards
Conflict of interest
The authors have no conflicts of interest.
- Akazawa, C., Shigemoto, R., Bessho, Y., Nakanishi, S., & Mizuno, N. (1994). Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats. The Journal of Comparative Neurology, 347(1), 150–160. https://doi.org/10.1002/cne.903470112.CrossRefPubMedGoogle Scholar
- Berberich, S., Punnakkal, P., Jensen, V., Pawlak, V., Seeburg, P. H., Hvalby, Ø., et al. (2005). Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25(29), 6907–6910. https://doi.org/10.1523/JNEUROSCI.1905-05.2005.CrossRefGoogle Scholar
- Berretta, N., Ledonne, A., Mango, D., Bernardi, G., & Mercuri, N. B. (2012). Hippocampus versus entorhinal cortex decoupling by an NR2 subunit–specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy. Epilepsia, 53(5), e80–e84. https://doi.org/10.1111/j.1528-1167.2012.03420.x.CrossRefPubMedGoogle Scholar
- Borbély, S., Dobó, E., Czégé, D., Molnár, E., Bakos, M., Szucs, B., et al. (2009). Modification of ionotropic glutamate receptor-mediated processes in the rat hippocampus following repeated, brief seizures. Neuroscience, 159(1), 358–368. https://doi.org/10.1016/j.neuroscience.2008.12.027.CrossRefPubMedGoogle Scholar
- Chen, Q., He, S., Hu, X.-L., Yu, J., Zhou, Y., Zheng, J., et al. (2007). Differential roles of NR2A- and NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis. The Journal of Neuroscience, 27(3), 542–552. https://doi.org/10.1523/JNEUROSCI.3607-06.2007.CrossRefPubMedGoogle Scholar
- Dzhala, V. I., & Staley, K. J. (2003). Transition from interictal to ictal activity in limbic networks in vitro. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 23(21), 7873–7880.Google Scholar
- Edman, S., McKay, S., Macdonald, L. J., Samadi, M., Livesey, M. R., Hardingham, G. E., et al. (2012). TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner. Neuropharmacology, 63(3), 441–449. https://doi.org/10.1016/j.neuropharm.2012.04.027.CrossRefPubMedGoogle Scholar
- Endele, S., Rosenberger, G., Geider, K., Popp, B., Tamer, C., Stefanova, I., et al. (2010). Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nature Genetics, 42(11), 1021–1026. https://doi.org/10.1038/ng.677.CrossRefPubMedGoogle Scholar
- Kumar, S. S., & Huguenard, J. R. (2003). Pathway-specific differences in subunit composition of synaptic NMDA receptors on pyramidal neurons in neocortex. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 23(31), 10074–10083.Google Scholar
- Le Bail, M., Martineau, M., Sacchi, S., Yatsenko, N., Radzishevsky, I., Conrod, S., et al. (2015). Identity of the NMDA receptor coagonist is synapse specific and developmentally regulated in the hippocampus. Proceedings of the National Academy of Sciences of the United States of America, 112(2), E204–E213. https://doi.org/10.1073/pnas.1416668112.CrossRefPubMedGoogle Scholar
- Moser, J., Kilb, W., Werhahn, K.-J., & Luhmann, H. J. (2006). Early developmental alterations of low-Mg2+ -induced epileptiform activity in the intact corticohippocampal formation of the newborn mouse in vitro. Brain Research, 1077(1), 170–177. https://doi.org/10.1016/j.brainres.2006.01.024.CrossRefPubMedGoogle Scholar
- Ye, G.-L., Yi, S., Gamkrelidze, G., Pasternak, J. F., & Trommer, B. L. (2005). AMPA and NMDA receptor-mediated currents in developing dentate gyrus granule cells. Brain Research. Developmental Brain Research, 155(1), 26–32. https://doi.org/10.1016/j.devbrainres.2004.12.002.CrossRefPubMedGoogle Scholar
- Yuan, H., Myers, S. J., Wells, G., Nicholson, K. L., Swanger, S. A., Lyuboslavsky, P., et al. (2015). Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effects. Neuron, 85(6), 1305–1318. https://doi.org/10.1016/j.neuron.2015.02.008.CrossRefPubMedPubMedCentralGoogle Scholar